Helsinki University announced on 28 March that the US National Institutes of Health has granted the university's diabetes research programme a three-year extension grant worth $1.85 million (€1.4m).
The funding is given to the Trial to Reduce Insulin-Dependent Diabetes Mellitus in the Genetically at Risk (TRIGR) project that conducts research on the causes and development of children’s type 1 diabetes. The preliminary research found that the type of breast milk substitute given to babies with a genetic risk of diabetes may make a difference in the timing of development of childhood diabetes.
This article is only available to Research Professional News subscribers or Pivot-RP users.
If you are a Research Professional News subscriber you can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.